cell-free DNA

MSK-ACCESS sequences 129 cancer-associated genes selected from the MSK-IMPACT assay and is designed to detect gene alterations in cfDNA specimen.

Resolution is developing its liquid biopsy assay as a companion diagnostic for niraparib in metastatic castration-resistant prostate cancer.

In almost 1,000 twin pregnancies with known outcomes, cell-free DNA screening of maternal blood correctly classified trisomy 21 cases 94 percent of the time.

According to Natantis, researchers will be able to use the device to extract cell-free nucleic acids from whole blood in 45 minutes.

SensID specializes in the development, manufacture, and marketing or reference materials and quality controls for DNA-based diagnostics.

The company's first quarter revenues were driven by sales of its noninvasive prenatal screening and carrier screening tests.

Take2 was founded by Chinese University of Hong Kong researchers and will commercialize a cell-free DNA test for early cancer detection.